NM_005391.5:c.282T>C

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_005391.5(PDK3):​c.282T>C​(p.Tyr94Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,152,887 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 32 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., 3 hem., cov: 21)
Exomes 𝑓: 0.000072 ( 0 hom. 29 hem. )

Consequence

PDK3
NM_005391.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.172

Publications

0 publications found
Variant links:
Genes affected
PDK3 (HGNC:8811): (pyruvate dehydrogenase kinase 3) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle, and thus is one of the major enzymes responsible for the regulation of glucose metabolism. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, and phosphorylation results in inactivation of PDH. The protein encoded by this gene is one of the three pyruvate dehydrogenase kinases that inhibits the PDH complex by phosphorylation of the E1 alpha subunit. This gene is predominantly expressed in the heart and skeletal muscles. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
PDK3 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease X-linked dominant 6
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-24498862-T-C is Benign according to our data. Variant chrX-24498862-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 541115.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.172 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDK3NM_005391.5 linkc.282T>C p.Tyr94Tyr synonymous_variant Exon 3 of 11 ENST00000379162.9 NP_005382.1 Q15120-1
PDK3NM_001142386.3 linkc.282T>C p.Tyr94Tyr synonymous_variant Exon 3 of 12 NP_001135858.1 Q15120-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDK3ENST00000379162.9 linkc.282T>C p.Tyr94Tyr synonymous_variant Exon 3 of 11 1 NM_005391.5 ENSP00000368460.4 Q15120-1
PDK3ENST00000568479.2 linkc.282T>C p.Tyr94Tyr synonymous_variant Exon 3 of 12 6 ENSP00000498864.1 Q15120-2
PDK3ENST00000493226.2 linkn.494T>C non_coding_transcript_exon_variant Exon 3 of 3 5
PDK3ENST00000648777.1 linkn.282T>C non_coding_transcript_exon_variant Exon 3 of 12 ENSP00000497727.1 Q15120-1

Frequencies

GnomAD3 genomes
AF:
0.0000916
AC:
10
AN:
109179
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000334
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00345
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000154
AC:
24
AN:
156082
AF XY:
0.000218
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00362
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000137
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000719
AC:
75
AN:
1043708
Hom.:
0
Cov.:
21
AF XY:
0.0000893
AC XY:
29
AN XY:
324814
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24013
American (AMR)
AF:
0.00
AC:
0
AN:
29715
Ashkenazi Jewish (ASJ)
AF:
0.00321
AC:
59
AN:
18364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29316
South Asian (SAS)
AF:
0.00
AC:
0
AN:
48830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40074
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3764
European-Non Finnish (NFE)
AF:
0.0000124
AC:
10
AN:
805705
Other (OTH)
AF:
0.000137
AC:
6
AN:
43927
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000916
AC:
10
AN:
109179
Hom.:
0
Cov.:
21
AF XY:
0.0000952
AC XY:
3
AN XY:
31513
show subpopulations
African (AFR)
AF:
0.0000334
AC:
1
AN:
29966
American (AMR)
AF:
0.00
AC:
0
AN:
10135
Ashkenazi Jewish (ASJ)
AF:
0.00345
AC:
9
AN:
2608
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3512
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2523
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52514
Other (OTH)
AF:
0.00
AC:
0
AN:
1470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000609
Hom.:
4
Bravo
AF:
0.0000567

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Charcot-Marie-Tooth disease X-linked dominant 6 Benign:1
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.3
DANN
Benign
0.42
PhyloP100
0.17
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201198782; hg19: chrX-24516979; API